Rozpędek-Kamińska, W.; Galita, G.; Siwecka, N.; Carroll, S.L.; Diehl, J.A.; Kucharska, E.; Pytel, D.; Majsterek, I.
The Potential Role of Small-Molecule PERK Inhibitor LDN-0060609 in Primary Open-Angle Glaucoma Treatment. Int. J. Mol. Sci. 2021, 22, 4494.
https://doi.org/10.3390/ijms22094494
AMA Style
Rozpędek-Kamińska W, Galita G, Siwecka N, Carroll SL, Diehl JA, Kucharska E, Pytel D, Majsterek I.
The Potential Role of Small-Molecule PERK Inhibitor LDN-0060609 in Primary Open-Angle Glaucoma Treatment. International Journal of Molecular Sciences. 2021; 22(9):4494.
https://doi.org/10.3390/ijms22094494
Chicago/Turabian Style
Rozpędek-Kamińska, Wioletta, Grzegorz Galita, Natalia Siwecka, Steven L. Carroll, John Alan Diehl, Ewa Kucharska, Dariusz Pytel, and Ireneusz Majsterek.
2021. "The Potential Role of Small-Molecule PERK Inhibitor LDN-0060609 in Primary Open-Angle Glaucoma Treatment" International Journal of Molecular Sciences 22, no. 9: 4494.
https://doi.org/10.3390/ijms22094494
APA Style
Rozpędek-Kamińska, W., Galita, G., Siwecka, N., Carroll, S. L., Diehl, J. A., Kucharska, E., Pytel, D., & Majsterek, I.
(2021). The Potential Role of Small-Molecule PERK Inhibitor LDN-0060609 in Primary Open-Angle Glaucoma Treatment. International Journal of Molecular Sciences, 22(9), 4494.
https://doi.org/10.3390/ijms22094494